| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 May 24 | PGEN Precigen | Option to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 1.4 | 1,803,000 | 2.52 mm | 1,803,000 |
| 5 Apr 24 | PGEN Precigen | Common Stock | Payment of exercise | Dispose F | No | No | 1.4 | 410,357 | 574.50 k | 2,221,076 |
| 5 Apr 24 | PGEN Precigen | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,071,429 | 0.00 | 2,631,433 |
| 5 Apr 24 | PGEN Precigen | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,071,429 | 0.00 | 0 |
| 5 Apr 24 | PGEN Precigen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,071,429 | 0.00 | 1,071,429 |
| 3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.38 | 20,250 | 169.70 k | 0 |
| 3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.48 | 25,000 | 87.00 k | 0 |
| 3 Apr 24 | KNTE Kinnate Biopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.38 | 40,501 | 987.41 k | 0 |
| 25 Aug 23 | PGEN Precigen | Common Stock | Sell | Dispose S | No | Yes | 1.53 | 76,969 | 117.76 k | 1,560,004 |
| 23 Aug 23 | PGEN Precigen | Common Stock | Option exercise | Acquire M | No | No | 0 | 141,587 | 0.00 | 1,636,973 |
